<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">JBRA Assist Reprod</journal-id><journal-id journal-id-type="iso-abbrev">JBRA Assist Reprod</journal-id><journal-id journal-id-type="publisher-id">jbra</journal-id><journal-title-group><journal-title>JBRA Assisted Reproduction</journal-title></journal-title-group><issn pub-type="ppub">1517-5693</issn><issn pub-type="epub">1518-0557</issn><publisher><publisher-name>Brazilian Society of Assisted Reproduction</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28333029</article-id><article-id pub-id-type="pmc">5365197</article-id><article-id pub-id-type="doi">10.5935/1518-0557.20170008</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Low concentration of hyaluronidase for oocyte denudation can improve
fertilization rates and embryo quality</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>de Moura</surname><given-names>Bernardo R L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Gurgel</surname><given-names>Mariana C A</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Machado</surname><given-names>Suelen PP</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Marques</surname><given-names>Priscila A</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rolim</surname><given-names>Juliana R</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>de Lima</surname><given-names>Marcelo C</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Salgueiro</surname><given-names>Lister L</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Cl&#x000ed;nica F&#x000e9;rtilis de Medicina Reprodutiva, Sorocaba,
SP, Brazil</aff><aff id="aff2"><label>2</label>Universidade Anhembi Morumbi, S&#x000e3;o Paulo, SP, Brazil</aff><author-notes><corresp id="c1"><bold>Corresponding author:</bold> Bernardo R. L. Moura, Cl&#x000ed;nica
F&#x000e9;rtilis de Reprodu&#x000e7;&#x000e3;o Assistida. E-mail:
<email>bernardorlm@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jan-Mar</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2017</year></pub-date><volume>21</volume><issue>1</issue><fpage>27</fpage><lpage>30</lpage><history><date date-type="received"><day>16</day><month>8</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>Hyaluronidase enzyme is an extremely important factor for the process of
oocyte denudation, but little is known about its negative effects.</p></sec><sec><title>Methods</title><p>This prospective randomized study analyzed the results of using different
concentrations of hyaluronidase (Diluted: 8IU/mL and Normal: 80IU/mL) used
for denudation of sibling-oocytes for 22 women undergoing treatment for
assisted reproduction by ICSI. A total of 192 oocytes were injected, being
104 for group I (diluted) and 88 for group II (normal). We analyzed
fertilization rate, cleavage, embryo quality at 48 and 72 hours and number
of transferred embryos in each group.</p></sec><sec><title>Results</title><p>The diluted enzyme group showed better results in fertilization rates (92.3%
vs. 80.6%), mean cleavage (4.18 &#x000b1; 2.57 vs. 3.09 &#x000b1; 1.90), in
48-hour embryos A and A + B (60.9% vs. 44.1% and 90.2% vs. 82.3%) and at 72
hours (45.6% vs. 36.8% and 77.1% vs 66.2%), and number of embryos selected
for transfer (61.8% vs. 38.1%). The overall pregnancy rate was 59.1%.</p></sec><sec><title>Conclusion</title><p>This study demonstrates that the use of 8 IU/mL of hyaluronidase, according
to the following protocol, is beneficial and can be successfully used for
oocyte denudation, and it is also economically advantageous to the
laboratory</p></sec></abstract><kwd-group><kwd>ICSI</kwd><kwd>Hyaluronidase</kwd><kwd>oocyte denudation</kwd><kwd><italic>cumulus</italic>- oocyte complex</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>With the advent of Intracytoplasmic Sperm Injection technique (ICSI) there was a
great advance in assisted reproductive technology (ART), and thousands of infertile
couples were benefited. The development of this technique led to the need for a
better classification of oocytes, as well as the choice of the most capable sperm
for fertilization purposes.</p><p>The success of this technique depends of some factors, such as specific equipment,
competent embryologists (<xref rid="r6" ref-type="bibr">Gordts <italic>et
al</italic>., 1995</xref>), oocyte quality (<xref rid="r9" ref-type="bibr">Liu <italic>et al</italic>., 1995</xref>), zona pellucida penetration, oolema
rupture (<xref rid="r11" ref-type="bibr">Nagy <italic>et al</italic>., 1995</xref>;
<xref rid="r12" ref-type="bibr">Palermo <italic>et al</italic>., 1996</xref>)
and sperm viability (<xref rid="r11" ref-type="bibr">Nagy <italic>et al</italic>.,
1995</xref>).</p><p>Not all oocytes obtained through follicular aspiration have competence and maturity
to be fertilized; therefore, the oocytes must be previously classified to the moment
of injection according to its maturity degree. However, this classification is only
possible after the removal of the cumulus and corona cells surrounding the oocyte,
and this process is called oocyte denudation (<xref rid="r3" ref-type="bibr">De Vos
<italic>et al</italic>., 2008</xref>).</p><p>Oocyte denudation is a crucial process that demands extreme caution and experience
from the embryologist, because it combines two actions: one mechanic and one
enzymatic. Therefore, there are some criteria needed to preserve cell quality. After
denudation, the ideal is to see the extrusion of the first polar body, which means
that the oocyte is in the second metaphase. This oocyte cleaning process
(denudation) is extremely important, because besides classifying the oocyte, it
allows the visualization of morphological alterations, such as intracytoplasmic
granulation, fragmentation of the polar body and increased perivitelline space, then
enabling the selection of more viable oocytes for fertilization (<xref rid="r5" ref-type="bibr">Ebner <italic>et al</italic>., 2006</xref>).</p><p>The enzyme used for denudation is hyaluronidase, this enzyme digests the hyaluronic
acid interspaced between the cumulus cells (<xref rid="r10" ref-type="bibr">Mahadevan &#x00026; Trounson, 1985</xref>). In many laboratories, the standard
concentration used is 80 IU/mL, as suggested by <xref rid="r7" ref-type="bibr">Joris
<italic>et al</italic>. (1998)</xref>. Previously to the establishment of
this concentration, the increase in degeneration and parthenogenetic problem rates
were frequent with the use of higher concentrations of this enzyme. The results
published by <xref rid="r18" ref-type="bibr">Van de Velde <italic>et al</italic>.
(1997)</xref> found that lower concentration of hyaluronidase, using a higher
caliber pipette, can effectively decrease the time of oocyte exposure to the enzyme.
Therefore, using a protocol with short exposure for removal of cumulus cells is
fundamental, because although hyaluronidase dissociates the cells from the cumulus
artificially, it can also damage the oocyte in several areas.</p><p>On the other hand, some authors believe that the long exposure (around 30 min)
together with high concentrations of hyaluronidase (50-250 IU/mL) is not a
triggering factor for the parthenogenetic activation of the oocyte. However, there
is a lack of understanding about the effects of the enzyme on human oocytes (<xref rid="r8" ref-type="bibr">Laufer <italic>et al</italic>., 1984</xref>; <xref rid="r10" ref-type="bibr">Mahadevan &#x00026; Trounson, 1985</xref>; <xref rid="r14" ref-type="bibr">Pickering <italic>et al</italic>., 1988</xref>; <xref rid="r2" ref-type="bibr">Abramczuk &#x00026; Lopata, 1990</xref>).</p><p>Until now, few studies have tested the possible effects of different concentrations
of hyaluronidase in sibling-oocytes. This study aimed to evaluate the effectiveness
of the enzyme and compare different laboratorial parameters such as fertilization
and cleavage rates, embryo quality and number of transferred embryos using two
different concentrations of hyaluronidase (80 and 8 IU/mL) in sibling-oocytes.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><p>The protocols and procedures used in the present study were approved by the
Institutional Board Review (IBR) from F&#x000e9;rtilis Clinic of Assisted
Reproduction. This prospective and randomized study included twenty-two patients
submitted to Assisted Reproduction treatment between January and May 2011.</p><p>A randomized sibling-oocyte trial was started to evaluate the effectiveness and
possible influence of diluted concentration of 8IU/mL of hyaluronidase when compared
with the standardized concentration of 80IU/mL of hyaluronidase. Patients with over
four fresh oocytes were included at this study, regardless other associated clinical
factors. As for exclusion criteria, we list: patients with less than four oocytes,
total failure of fertilization after ICSI and absence of embryos for transfer. By
using a pair of dishes for sibling oocytes from each patient in a paired study
design, differences in patient characteristics, such as female age, rank of trial,
duration and origin of infertility, were taken off.</p><p>All the patients were submitted to controlled ovarian hyperstimulation, using long
term protocol with Gonadotropin Releasing Hormone (GnRH) agonist, as suggested by
previous studies (<xref rid="r4" ref-type="bibr">Dozortsev <italic>et al</italic>.,
2004</xref>). Oocytes were recovered by follicular aspiration guided by
transvaginal ultrasound, 35 hours after the administration of Human Chorionic
Gonadotropin (hCG).</p><p>After aspiration, follicular liquid checking and separation of oocytes, the denudated
hyaluronidase (Hyase, Irvine Scientific, California, USA) diluted in modified HTF
medium (mHTF) (HEPES-buffered; Irvine Scientific, California, USA) supplemented with
15% SSS (Synthetic Serum Substitute, Irvine Scientific, California, USA), at a final
concentration of 8 IU/mL. In group II (GII), oocyte denudation was performed with 80
IU/mL hyaluronidase. In the case of having an odd number of oocytes, the
supernumerary was placed on GI, according to a standardized random group decision.
Aiming to maintain impartiality in the separation of oocytes, the focus of the
stereomicroscope was withdrawn so there was no clear visualization of the cumulus -
oocyte complex (COCs).</p><p>The denudation process was accomplished in two steps. The first (enzymatic) was
performed subsequently to the separation of the groups. Separately, COCs from GI and
GII were immersed in hyaluronidase in the correspondent concentration for each
group, with a large diameter glass Pasteur pipette (5.75" IVF Pasteur Pipets,
Origio, Denmark) performing movements of entry and exit from the pipette for 30
seconds, followed by washing in mHTF medium supplemented with 15% SSS to remove the
excess enzyme. Culture was performed in the groups GI and GII in a double gap dish
(BD Falcon 35-3037, Nova Jersey, USA) with 1mL of SSM (Single Step Medium, Irvine
Scientific, California, USA) supplemented with 15% of SSS and covered with mineral
oil (Oil for embryo culture, Irvine Scientific, California, USA).</p><p>The oocytes remained in culture incubators (Forma Series II model: 3110;
Water-Jacketed CO<sub>2</sub> Incubators, USA) at an atmosphere of 5.5%
CO<sub>2</sub>, at37&#x000ba;C for one hour and then submitted to the mechanic step of
denudation. On the stereomicroscope, we found COCs on the bottom of the plate, with
few cells left around the oocyte in both groups. Remaining cells were removed using
a manipulation pipette (Flexipet Adjustable Handle Set, Cook Medical, Indiana, USA)
with the use of a 130 &#x000b5;m internal diameter tip (Stripper Tips - Handle Cook,
Indiana, USA). Oocytes were moved in and out of the pipette until total denudation
and visualization for classification of nuclear maturation. By the end of denudation
and classification, the oocytes were placed in 50 &#x000b5;L drops of SSM with 15% of
SSS covered with 4 mL of mineral oil and incubated until ICSI.</p><p>ICSI was performed in mature oocytes three hours after the aspiration as previously
described by <xref rid="r13" ref-type="bibr">Palermo <italic>et al</italic>.
(1992)</xref> and <xref rid="r1" ref-type="bibr">Abdelmassih <italic>et
al</italic>. (1996)</xref>. Fertilization and cleavage checking were always
performed by the same embryologist, without identifying the groups. The criteria
used were the same as described by Dozortzev <italic>et al</italic>. (2004).</p><p>For embryo transfer (ET), a catheter (Sidney IVF - Handle Cook, Indiana, USA)
connected to a Terumo, 1.0 mL syringe (Terumo Medical do Brasil, S&#x000e3;o Paulo,
Brazil) was used. The catheter was previously washed with transfer medium (mHTF +
15% SSS) than the embryos were loaded and injected into the uterus under pelvic
ultrasound guidance. Vaginal administration of progesterone was initiated upon the
oocytes aspiration day (600 mg/day Utrogestan; Besins Laboratories, Paris, France)
and was maintained until pregnancy evaluation (12 days after the transfer). Serum
levels of &#x003b2;-hCG were measured on day twelve after the transfer. Clinical
pregnancy was determined by visualization of heart beat trough ultrasound within six
weeks' gestation.</p><p>Statistical significance was determined by Wilcoxon test. Differences were considered
significant for <italic>p</italic> &#x02264; 0.05.</p></sec><sec sec-type="results"><title>RESULTS</title><p>A total of two hundred twenty-one oocytes were aspirated from twenty-two cycles of
IVF-ICSI analyzed. One hundred ninety-two oocytes were classified as MII and
injected, being 104 (54%) in GI and 88 (46%) in GII. Data related to average age,
oocytes, transferred embryos and pregnancy rates are described on <xref ref-type="table" rid="t1">Table 1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>General characteristics of the participants' cycles in the study</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">N</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Total <italic>#</italic> of Patients</td><td align="center" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">Age<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td><td align="center" rowspan="1" colspan="1">33.7 &#x000b1; 5.65</td></tr><tr><td align="left" rowspan="1" colspan="1">Total oocytes</td><td align="center" rowspan="1" colspan="1">221</td></tr><tr><td align="left" rowspan="1" colspan="1">Oocytes<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td><td align="center" rowspan="1" colspan="1">10.04 &#x000b1; 4.50</td></tr><tr><td align="left" rowspan="1" colspan="1">Total MII oocytes<sup><xref ref-type="table-fn" rid="TFN3">c</xref></sup></td><td align="center" rowspan="1" colspan="1">192</td></tr><tr><td align="left" rowspan="1" colspan="1">Injected (MII)<sup><xref ref-type="table-fn" rid="TFN1">a</xref>,<xref ref-type="table-fn" rid="TFN3">c</xref></sup></td><td align="center" rowspan="1" colspan="1">8.72 &#x000b1; 4.34</td></tr><tr><td align="left" rowspan="1" colspan="1">Total Embryos Transferred</td><td align="center" rowspan="1" colspan="1">55</td></tr><tr><td align="left" rowspan="1" colspan="1">Embryos Transferred<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td><td align="center" rowspan="1" colspan="1">2.5 &#x000b1; 0.67</td></tr><tr><td align="left" rowspan="1" colspan="1">Pregnancy rates (%)<sup><xref ref-type="table-fn" rid="TFN2">b</xref></sup></td><td align="center" rowspan="1" colspan="1">59.1 (13/22)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p>Values are Mean &#x000b1; Standard Deviation (SD)</p></fn><fn id="TFN2"><label>b</label><p>Mean percentage per cycle</p></fn><fn id="TFN3"><label>c</label><p>MII, mature metaphase-II oocytes</p></fn></table-wrap-foot></table-wrap><p>Data on laboratorial parameters analyzed in both groups are on <xref ref-type="table" rid="t2">Table 2</xref>. As demonstrated, the first group showed better results
when compared with the second group for the following parameters: fertilization
92.3% (96/104) vs. 80.6% (71/88), <italic>p</italic> = 0.006), grade A embryos (with
best morphology) in 48 hours (60.9% (56/92) vs. 44.1% (30/68), <italic>p</italic> =
0.006) and 72-hour cleavage (45.6% (42/92) vs. 36.8% (25/68), <italic>p</italic> =
0.044) besides higher index of embryos selected for transfer in GI (61.8% (34/55))
when compared with GII (38.8% (21/55)). For better analysis of embryo quality, data
of embryos with the best (grade A + B) and worst (grade C + D) quality were joined
for both analysis at 48 and 72 hours, and, again GI showed better results (48hs =
3.77 &#x000b1; 2.39 vs. 2.55 &#x000b1; 1.63, <italic>p =</italic> 0.004 and in 72hs =
3.23 &#x000b1; 2.37 vs. 2.05 &#x000b1; 1.79, <italic>p</italic> = 0.006).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Average value of the results per group</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">GI (Diluted)</th><th align="center" rowspan="1" colspan="1">GII (Control)</th><th align="center" rowspan="1" colspan="1"><italic>p</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Average rate of injected oocytes</td><td align="center" rowspan="1" colspan="1">4.72 &#x000b1; 2.35</td><td align="center" rowspan="1" colspan="1">4.0 &#x000b1; 2.09</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">Fertilization average rate</td><td align="center" rowspan="1" colspan="1">4.36 &#x000b1; 2.49</td><td align="center" rowspan="1" colspan="1">3.22 &#x000b1; 1.87</td><td align="center" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">Cleavage average</td><td align="center" rowspan="1" colspan="1">4.18 &#x000b1; 2.57</td><td align="center" rowspan="1" colspan="1">3.09 &#x000b1; 1.90</td><td align="center" rowspan="1" colspan="1">0.010</td></tr><tr><td align="left" rowspan="1" colspan="1">48 hours' evaluation rate</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE A</td><td align="center" rowspan="1" colspan="1">2.54 &#x000b1; 2.21</td><td align="center" rowspan="1" colspan="1">1.36 &#x000b1; 1.67</td><td align="center" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE B</td><td align="center" rowspan="1" colspan="1">1.23 &#x000b1; 1.44</td><td align="center" rowspan="1" colspan="1">1.18 &#x000b1; 1.05</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE C</td><td align="center" rowspan="1" colspan="1">0.36 &#x000b1; 0.58</td><td align="center" rowspan="1" colspan="1">0.41 &#x000b1; 0.91</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE D</td><td align="center" rowspan="1" colspan="1">0.04 &#x000b1; 0.21</td><td align="center" rowspan="1" colspan="1">0.14 &#x000b1; 0.35</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE A + B</td><td align="center" rowspan="1" colspan="1">3.77 &#x000b1; 2.39</td><td align="center" rowspan="1" colspan="1">2.55 &#x000b1; 1.63</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE C + D</td><td align="center" rowspan="1" colspan="1">0.41 &#x000b1; 0.67</td><td align="center" rowspan="1" colspan="1">0.55 &#x000b1; 1.14</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">72 hours' evaluation rate</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE A</td><td align="center" rowspan="1" colspan="1">1.91 &#x000b1; 1.87</td><td align="center" rowspan="1" colspan="1">1.13 &#x000b1; 1.35</td><td align="center" rowspan="1" colspan="1">0.044</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE B</td><td align="center" rowspan="1" colspan="1">1.32 &#x000b1; 1.21</td><td align="center" rowspan="1" colspan="1">0.90 &#x000b1; 1.01</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE C</td><td align="center" rowspan="1" colspan="1">0.73 &#x000b1; 0.83</td><td align="center" rowspan="1" colspan="1">0.73 &#x000b1; 0.98</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE A + B</td><td align="center" rowspan="1" colspan="1">3.23 &#x000b1; 2.37</td><td align="center" rowspan="1" colspan="1">2.05 &#x000b1; 1.79</td><td align="center" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">GRADE C + D</td><td align="center" rowspan="1" colspan="1">0.96 &#x000b1; 1.17</td><td align="center" rowspan="1" colspan="1">1.05 &#x000b1; 1.29</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Average n&#x000ba; of transferred embryos</td><td align="center" rowspan="1" colspan="1">1.59 &#x000b1; 0.67</td><td align="center" rowspan="1" colspan="1">0.95 &#x000b1; 0.35</td><td align="center" rowspan="1" colspan="1">0.005</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>Each value represents mean &#x000b1; standard deviation, NS = not
significant</p></fn></table-wrap-foot></table-wrap><p>Each value represents mean &#x000b1; standard deviation, NS = Not Significant</p><p>There was no statistic difference between the groups regarding embryo quality
parameters in grades B, C, D and C + D upon evaluations at 48 and 72 hours. An
average of 2.5 &#x000b1; 0.67 embryos were transferred, being the maximum of 4
transferred embryos, varying according to patient's age and characteristics. The
general pregnancy rate of the patients in the study was 59.1% (13/22).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Our objective was to test a lower concentration of enzymes and its effectiveness at
denuding, COC and compare different laboratorial parameters such as fertilization
and cleavage rates, embryo quality and number of transferred embryos. The results of
the present study demonstrate that the diluted enzyme is effective for denuding
oocytes prior to ICSI treatment in this protocol. Furthermore, the data suggests
that this lower concentration of enzyme significantly improves fertilization rates
and positively affect embryo development compared to the standard concentration
product: Hyase.</p><p>The average rate of injected oocytes was significantly different between the groups
because of an odd number of oocytes, and it was randomly decided that every unpaired
oocyte would be designated to the first group. Although, it was not possible to
assess pregnancy rate in each group, to maintain the chances of pregnancy for the
patients, always the best morphology graded embryos were selected for transfer,
independent of the group where they were.</p><p>The times exposed to each solution were always the same, thirty seconds, between the
two groups, indicating that lower concentration is as effective as the traditionally
used hyaluronidase concentration for disrupting cumulus cells. However, the time
oocytes are in each solution is subjective in that each embryologist uses different
criteria before oocytes are removed. Many clinics use a hyaluronidase concentration
of 80 IU/mL, which would lead to shorter exposure times to hyaluronidase. <xref rid="r18" ref-type="bibr">Van de Velde. (1997)</xref> found that a lower
concentration of hyaluronidase and a pipette of larger diameter could effectively
limit the exposure time of oocytes to hyaluronidase.</p><p>Furthermore, those authors discuss the fact that using lower concentrations of
hyaluronidase could considerably reduce parthenogenic activation rates. In this
study, we could observe that in the group exposed to a lower concentration of
hyaluronidase had better fertilization rates and higher embryo quality. This leads
us to believe that the enzyme is not only related to parthenogen but also to
toxicity, which could lead the oocyte to lose its quality, fertilization and
cleavage viability, besides embryo quality, so finding a protocol that allows for
shorter exposure and effective removal of COC is critical (<xref rid="r18" ref-type="bibr">Van de Velde <italic>et al</italic>., 1997</xref>).</p><p><xref rid="r7" ref-type="bibr">Joris <italic>et al</italic>. (1998)</xref> suggested
80 IU/mL as an ideal concentration. Ever since only few studies were performed
aiming to correlate the possible toxic effects of hyaluronidase in several
laboratorial parameters of <italic>in vitro</italic> fertilization. Other studies
reported some trials using lower concentrations, such as 40 and 20 IU/mL, but they
only compared this bovine-derived enzyme to the recombinant enzyme, not supporting
our findings, but they also suggest some possible effects of toxicity that could
influence fertilization rates and embryo quality (<xref rid="r3" ref-type="bibr">De
Vos <italic>et al</italic>., 2008</xref>; <xref rid="r15" ref-type="bibr">Taylor
<italic>et al</italic>., 2006</xref>).</p><p>Hyaluronidase is, without a doubt, extremely important, because it aids in oocyte
activation and it improves fertilization rates (<xref rid="r16" ref-type="bibr">Tesarik <italic>et al</italic>., 1994</xref>; <xref rid="r17" ref-type="bibr">1995</xref>). However, there is little literature data about its possible
negative effects and its ideal concentration for oocyte denudation. According to
<xref rid="r12" ref-type="bibr">Palermo <italic>et al</italic>. (1996)</xref>,
about 17% of oocytes present parthenogenetic activation during denudation, which
leads to a constant search for improvements in this process.</p><p>The results of the present study suggest that the lower concentration of enzyme, at
8,0 IU/mL (Hyase), is effective for use in an ICSI treatment program for obtaining
high fertilization and developmental rates, together with better embryo quality.
This study also shows an economic alternative, since the same amount of
hyaluronidase used nowadays for denudation in one cycle, could be potentially used
for ten cycles. However, future studies are needed to support these findings.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="r1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelmassih</surname><given-names>R</given-names></name><name><surname>Sollia</surname><given-names>S</given-names></name><name><surname>Moretto</surname><given-names>M</given-names></name><name><surname>Acosta</surname><given-names>AA</given-names></name></person-group><article-title>Female age is an important parameter to predict treatment outcome
in intracytoplasmic sperm injection</article-title><source>Fertil Steril</source><year>1996</year><volume>65</volume><fpage>573</fpage><lpage>577</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0015-0282(16)58156-4">http://dx.doi.org/10.1016/S0015-0282(16)58156-4</ext-link><pub-id pub-id-type="pmid">8774289</pub-id></element-citation></ref><ref id="r2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramczuk</surname><given-names>JW</given-names></name><name><surname>Lopata</surname><given-names>A</given-names></name></person-group><article-title>Resistance of human follicular oocytes to parthenogenetic
activation: DNA distribution and content in oocytes maintained <italic>in
vitro</italic></article-title><source>Hum Reprod</source><year>1990</year><volume>5</volume><fpage>578</fpage><lpage>581</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/oxfordjournals.humrep.a137148">http://dx.doi.org/10.1093/oxfordjournals.humrep.a137148</ext-link><pub-id pub-id-type="pmid">2394788</pub-id></element-citation></ref><ref id="r3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vos</surname><given-names>A</given-names></name><name><surname>Van Landuyt</surname><given-names>L</given-names></name><name><surname>Van Ranst</surname><given-names>H</given-names></name><name><surname>Vandermonde</surname><given-names>A</given-names></name><name><surname>D'Haese</surname><given-names>V</given-names></name><name><surname>Sterckx</surname><given-names>J</given-names></name><name><surname>Haentjens</surname><given-names>P</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name><name><surname>Van der Elst</surname><given-names>J</given-names></name></person-group><article-title>Randomized sibling-oocyte study using recombinant human
hyaluronidase versus bovine derived Sigma hyaluronidase in ICSI
patients</article-title><source>Hum Reprod</source><year>2008</year><volume>23</volume><fpage>1815</fpage><lpage>1819</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/humrep/den212">http://dx.doi.org/10.1093/humrep/den212</ext-link><pub-id pub-id-type="pmid">18540008</pub-id></element-citation></ref><ref id="r4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dozortsev</surname><given-names>D</given-names></name><name><surname>Nagy</surname><given-names>P</given-names></name><name><surname>Abdelmassih</surname><given-names>S</given-names></name><name><surname>Oliveira</surname><given-names>F</given-names></name><name><surname>Brasil</surname><given-names>A</given-names></name><name><surname>Abdelmassih</surname><given-names>V</given-names></name><name><surname>Diamond</surname><given-names>M</given-names></name><name><surname>Abdelmassih</surname><given-names>R</given-names></name></person-group><article-title>The optimal time for intracytoplasmic sperm injection in the
human is from 37 to 41 hours after administration of human chorionic
gonadotropin</article-title><source>Fertil Steril</source><year>2004</year><volume>82</volume><fpage>1492</fpage><lpage>1496</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.fertnstert.2004.09.002">http://dx.doi.org/10.1016/j.fertnstert.2004.09.002</ext-link><pub-id pub-id-type="pmid">15589848</pub-id></element-citation></ref><ref id="r5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebner</surname><given-names>T</given-names></name><name><surname>Moser</surname><given-names>M</given-names></name><name><surname>Sommergruber</surname><given-names>M</given-names></name><name><surname>Shebl</surname><given-names>O</given-names></name><name><surname>Tews</surname><given-names>G</given-names></name></person-group><article-title>Incomplete denudation of oocytes prior to ICSI enhances embryo
quality and blastocyst development</article-title><source>Hum Reprod</source><year>2006</year><volume>21</volume><fpage>2972</fpage><lpage>2977</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/humrep/del272">http://dx.doi.org/10.1093/humrep/del272</ext-link><pub-id pub-id-type="pmid">16835216</pub-id></element-citation></ref><ref id="r6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordts</surname><given-names>S</given-names></name><name><surname>Vercruyssen</surname><given-names>M</given-names></name><name><surname>Roziers</surname><given-names>P</given-names></name><name><surname>Bassil</surname><given-names>S</given-names></name><name><surname>Demylle</surname><given-names>D</given-names></name><name><surname>Donnez</surname><given-names>J</given-names></name><name><surname>Campo</surname><given-names>R</given-names></name></person-group><article-title>Recent developments in assisted fertilization</article-title><source>Hum Reprod</source><year>1995</year><volume>10</volume><fpage>107</fpage><lpage>114</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/humrep/10.suppl_1.107">http://dx.doi.org/10.1093/humrep/10.suppl_1.107</ext-link><pub-id pub-id-type="pmid">8592026</pub-id></element-citation></ref><ref id="r7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joris</surname><given-names>H</given-names></name><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Van de Velde</surname><given-names>H</given-names></name><name><surname>De Vos</surname><given-names>A</given-names></name><name><surname>Van Steirteghem</surname><given-names>A</given-names></name></person-group><article-title>Intracytoplasmic sperm injection: laboratory set-up and injection
procedure</article-title><source>Hum Reprod</source><year>1998</year><volume>13</volume><fpage>76</fpage><lpage>86</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/humrep/13.suppl_1.76">http://dx.doi.org/10.1093/humrep/13.suppl_1.76</ext-link><pub-id pub-id-type="pmid">9663772</pub-id></element-citation></ref><ref id="r8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laufer</surname><given-names>N</given-names></name><name><surname>Tarlatzis</surname><given-names>BC</given-names></name><name><surname>DeCherney</surname><given-names>AH</given-names></name><name><surname>Masters</surname><given-names>JT</given-names></name><name><surname>Haseltine</surname><given-names>FP</given-names></name><name><surname>MacLusky</surname><given-names>N</given-names></name><name><surname>Naftolin</surname><given-names>F</given-names></name></person-group><article-title>Asynchrony between cumulus-corona cell complex and oocyte
maturation after human menopausal gonadotropin treatment for <italic>in
vitro</italic> fertilization</article-title><source>Fertil Steril</source><year>1984</year><volume>42</volume><fpage>366</fpage><lpage>372</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0015-0282(16)48074-X">http://dx.doi.org/10.1016/S0015-0282(16)48074-X</ext-link><pub-id pub-id-type="pmid">6432586</pub-id></element-citation></ref><ref id="r9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Joris</surname><given-names>H</given-names></name><name><surname>Tournaye</surname><given-names>H</given-names></name><name><surname>Smitz</surname><given-names>J</given-names></name><name><surname>Camus</surname><given-names>M</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name><name><surname>Van Steirteghem</surname><given-names>A</given-names></name></person-group><article-title>Analysis of 76 total fertilization failure cycles out of 2732
intracytoplasmic sperm injection cycles</article-title><source>Hum Reprod</source><year>1995</year><volume>10</volume><fpage>2630</fpage><lpage>2636</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/oxfordjournals.humrep.a135758">http://dx.doi.org/10.1093/oxfordjournals.humrep.a135758</ext-link><pub-id pub-id-type="pmid">8567783</pub-id></element-citation></ref><ref id="r10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahadevan</surname><given-names>MM</given-names></name><name><surname>Trounson</surname><given-names>AO</given-names></name></person-group><article-title>Removal of the cumulus oophorus from the human oocyte for
<italic>in vitro</italic> fertilization</article-title><source>Fertil Steril</source><year>1985</year><volume>43</volume><fpage>263</fpage><lpage>267</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0015-0282(16)48383-4">http://dx.doi.org/10.1016/S0015-0282(16)48383-4</ext-link><pub-id pub-id-type="pmid">3967784</pub-id></element-citation></ref><ref id="r11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Joris</surname><given-names>H</given-names></name><name><surname>Bocken</surname><given-names>G</given-names></name><name><surname>Desmet</surname><given-names>B</given-names></name><name><surname>Van Ranst</surname><given-names>H</given-names></name><name><surname>Vankelecom</surname><given-names>A</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name><name><surname>Van Steirteghem</surname><given-names>AC</given-names></name></person-group><article-title>The influence of the site of sperm deposition and mode of oolemma
breakage at intracytoplasmic sperm injection on fertilization and embryo
development rates</article-title><source>Hum Reprod</source><year>1995</year><volume>10</volume><fpage>3171</fpage><lpage>3177</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/oxfordjournals.humrep.a135881">http://dx.doi.org/10.1093/oxfordjournals.humrep.a135881</ext-link><pub-id pub-id-type="pmid">8822437</pub-id></element-citation></ref><ref id="r12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palermo</surname><given-names>GD</given-names></name><name><surname>Alikani</surname><given-names>M</given-names></name><name><surname>Bertoli</surname><given-names>M</given-names></name><name><surname>Colombero</surname><given-names>LT</given-names></name><name><surname>Moy</surname><given-names>F</given-names></name><name><surname>Cohen</surname><given-names>J</given-names></name><name><surname>Rosenwaks</surname><given-names>Z</given-names></name></person-group><article-title>Oolema characteristics in relation to survival and fertilization
patterns of oocyte treated by intracytoplasmatic sperm
injection</article-title><source>Hum Reprod</source><year>1996</year><volume>11</volume><fpage>172</fpage><lpage>176</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/oxfordjournals.humrep.a019012">http://dx.doi.org/10.1093/oxfordjournals.humrep.a019012</ext-link><pub-id pub-id-type="pmid">8671181</pub-id></element-citation></ref><ref id="r13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palermo</surname><given-names>GD</given-names></name><name><surname>Joris</surname><given-names>H</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name><name><surname>Van Steirteghem</surname><given-names>AC</given-names></name></person-group><article-title>Pregnancies after intracytoplasmic injection of single
spermatozoon into an oocyte</article-title><source>Lancet</source><year>1992</year><volume>340</volume><fpage>17</fpage><lpage>18</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/0140-6736(92)92425-F">http://dx.doi.org/10.1016/0140-6736(92)92425-F</ext-link><pub-id pub-id-type="pmid">1351601</pub-id></element-citation></ref><ref id="r14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickering</surname><given-names>SJ</given-names></name><name><surname>Johnson</surname><given-names>MH</given-names></name><name><surname>Braude</surname><given-names>PR</given-names></name><name><surname>Houliston</surname><given-names>E</given-names></name></person-group><article-title>Cytoskeletal organization in fresh, aged and spontaneously
activated human oocytes</article-title><source>Hum Reprod</source><year>1988</year><volume>3</volume><fpage>978</fpage><lpage>989</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/oxfordjournals.humrep.a136828">http://dx.doi.org/10.1093/oxfordjournals.humrep.a136828</ext-link><pub-id pub-id-type="pmid">3204153</pub-id></element-citation></ref><ref id="r15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>TH</given-names></name><name><surname>Elliott</surname><given-names>T</given-names></name><name><surname>Colturato</surname><given-names>LF</given-names></name><name><surname>Straub</surname><given-names>RJ</given-names></name><name><surname>Mitchell-Leef</surname><given-names>D</given-names></name><name><surname>Nagy</surname><given-names>ZP</given-names></name></person-group><article-title>Comparison of bovine- and recombinant human-derived hyaluronidase
with regard to fertilization rates and embryo morphology in a sibling oocyte
model: a prospective, blinded, randomized study</article-title><source>Fertil Steril</source><year>2006</year><volume>85</volume><fpage>1544</fpage><lpage>1546</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.fertnstert.2005.10.053">http://dx.doi.org/10.1016/j.fertnstert.2005.10.053</ext-link><pub-id pub-id-type="pmid">16647383</pub-id></element-citation></ref><ref id="r16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesarik</surname><given-names>J</given-names></name><name><surname>Sousa</surname><given-names>M</given-names></name><name><surname>Testart</surname><given-names>J</given-names></name></person-group><article-title>Human oocyte activation after intracytoplasmic sperm
injection</article-title><source>Hum Reprod</source><year>1994</year><volume>9</volume><fpage>511</fpage><lpage>518</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/oxfordjournals.humrep.a138537">http://dx.doi.org/10.1093/oxfordjournals.humrep.a138537</ext-link><pub-id pub-id-type="pmid">8006144</pub-id></element-citation></ref><ref id="r17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesarik</surname><given-names>J</given-names></name><name><surname>Sousa</surname><given-names>M</given-names></name><name><surname>Mendoza</surname><given-names>C</given-names></name></person-group><article-title>Sperm-induced calcium oscillations of human oocytes show distinct
features in oocyte center and periphery</article-title><source>Mol Reprod Dev</source><year>1995</year><volume>41</volume><fpage>257</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">7654379</pub-id></element-citation></ref><ref id="r18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van de Velde</surname><given-names>H</given-names></name><name><surname>Nagy</surname><given-names>ZP</given-names></name><name><surname>Joris</surname><given-names>H</given-names></name><name><surname>De Vos</surname><given-names>A</given-names></name><name><surname>Van Steirteghem</surname><given-names>AC</given-names></name></person-group><article-title>Effects of different hyaluronidase concentrations and mechanical
procedures for cumulus cell removal on the outcome of intracytoplasmic sperm
injection</article-title><source>Hum Reprod</source><year>1997</year><volume>12</volume><fpage>2246</fpage><lpage>2250</lpage><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/humrep/12.10.2246">http://dx.doi.org/10.1093/humrep/12.10.2246</ext-link><pub-id pub-id-type="pmid">9402289</pub-id></element-citation></ref></ref-list></back></article>